Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Antibiotic discontinuation through an antibiotic treatment optimization program in emergency department patients with low suspicion of infection
Paula Martínez-de la Cruz; Leonor Moreno-Núñez; Sara Álvarez-Atienza; Sira Sanz-Márquez; José Francisco Valverde-Canovas; Juan Emilio Losa-García;
Enferm Infecc Microbiol Clin. 2023;41:423-5
Dalbavancin as sequential therapy in infective endocarditis: Real-life experience in elder and comorbid patients
Eduardo Aparicio-Minguijón; Jorge Boán; Antonio Terrón; Carlos Heredia; Cristina Puente; Asunción Pérez-Jacoiste Asín; M. Ángeles Orellana; Laura Domínguez; José Manuel Caro; M. Jesús López-Gude; Eva María Aguilar-Blanco; Andrea Eixerés-Esteve; Francisco López-Medrano;
Enferm Infecc Microbiol Clin. 2025;43:86-92
Dalbavancin as consolidation antibiotic treatment in infective endocarditis, cardiac implantable electronic devices infection and bacteremia: Clinical experience of 7 years
Alejandro Salinas-Botrán; Carmen Olmos-Blanco; David Fernández de Velasco-Pérez; Alicia Guzmán-Carreras; Alejandro Morales-Rosas; Daniel Gómez-Ramírez;
Enferm Infecc Microbiol Clin. 2025;43:71-9